Can paclitaxel and trastuzumab be given neoadjuvantly in Her2 positive breast cancer?  

While there is some rationale for this with the idea that if pCR is achieved with a minimalist approach then maybe one can omit additional chemotherapy the truth is that we have not yet demonstrated that this de-escalating method is valid and will achieve the same outcomes that are meaningful, e.g. ...